{"id":"W4412480038","doi":"10.1016/j.annonc.2025.05.400","title":"385TiP AZD0901 monotherapy in patients (pts) with advanced biliary tract cancer (BTC) expressing claudin18.2 (CLDN18.2): CLARITY-PanTumour01 substudy 3","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Biliary tract cancer; CLARITY; Internal medicine; Oncology; Cancer; Gemcitabine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006178024,0.000289149,0.0009065385,0.0002713473,0.0001965213,0.0006341895,0.000312642,0.0004300595,0.002645513],"category_scores_gemma":[0.0008360939,0.0002271092,0.0008195938,0.0006425306,0.0001782028,0.0004339475,0.0002740013,0.0006914631,0.0005149043],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000472808,"about_ca_system_score_gemma":0.000317619,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00169507,"about_ca_topic_score_gemma":0.006314427,"domain_scores_codex":[0.9996112,0.0001543597,0.00004008816,0.00007455163,0.00004669221,0.00007314733],"domain_scores_gemma":[0.9996907,0.00008804166,0.00008412851,0.00003309873,0.00003584202,0.00006824888],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2471645,0.001276415,0.5133886,0.002787093,0.01178614,0.0008602326,0.0002430896,0.001485623,0.02202141,0.0007690695,0.02788852,0.1703293],"study_design_scores_gemma":[0.03494802,0.03104331,0.8848644,0.0004421942,0.01039109,0.001242846,0.0002216058,0.001345103,0.002917156,0.0008392349,0.03166711,0.00007789234],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9738713,0.01354885,0.000176821,0.0005758213,0.0001602758,0.0001286879,0.006403148,0.00004297652,0.005092047],"genre_scores_gemma":[0.988383,0.003206277,0.0002186769,0.0005980264,0.0001526027,0.00009917252,0.006066502,0.000007964978,0.001267791],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002645513,"threshold_uncertainty_score":0.008850157,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05054774186181461,"score_gpt":0.3812779612181729,"score_spread":0.3307302193563583,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}